U.S. equities banked sharp gains on Monday as news from a biotech company Moderna trial stoked optimism about a potential Covid-19 vaccine. Stocks also got a boost from hopes the economy reopening will spur economic recovery. Here’s what happened:

4:20 pm: Market rally by the numbers

  • The Dow gained 912 points, 3.85%, its best daily performance since April 6 when it gained 7.73%, and third positive session in a row. 
  • The Dow hit its highest level since April 29 in Monday’s session.
  • Dow impact: Boeing had the most positive impact on the Dow, adding 106 points to the index.             
  • The S&P 500 gained 90 points, 3.15%, its best daily performance since April 6 when it gained 7.03%, and third positive session in a row. 
  • The S&P hit its highest level since March 6 in Monday’s session.   
  • SPY impact: Apple had the most positive impact on the SPY, adding 0.37 points to the ETF.   
  • The Nasdaq Composite gained 220 points, 2.44%, its best daily performance since April 29 when it gained 3.57%, and third positive session in a row. 
  • The Nasdaq hit its highest level since February 25 in Monday’s session. 
  • Nasdaq 100 impact: Apple had the most positive impact on the NDX, adding 25.2 points to the index.   
  • The Russell 2000 gained 6.10%, its best daily performance since April 6 when it gained 8.24%, and third positive session in a row for the first time since its six-day streak ending April 29.   
  • All 11 S&P Sectors were positive in Monday’s session, led by Energy, up 7.55%.  Health Care was the laggard, up 0.94%.     

4:01 pm: Stocks’ best day since April, Dow soars 900 points

U.S. equities surged on Monday as investors piled into riskier assets on hopes of a Covid-19 vaccine and a recovery to economic activity from the economy reopening. The Dow Jones Industrial Average jumped 911 points for its largest point gain since April 6. The S&P 500 rose 3.15% and the Nasdaq Composite rallied 2.44%. —Fitzgerald 

3:49 pm: Stocks accelerate gains into the close, Dow up 1,000

Stocks gained steam into the close, with the Dow Jones Industrial Average surging more than 1,000 points to its session high. The S&P 500 rose 3.6% and the Nasdaq Composite jumped 2.7%. — Fitzgerald 

3:01 pm: Final hour of trading: Wall Street headed for its best day since April

With roughly one hour left in the trading session, Wall Street was on pace to log its biggest one-day rally since April as investors cheer the possibility of a coronavirus vaccine coming soon. The Dow traded 900 points higher, or 3.8%. The S&P 500 climbed 3.3% while the Nasdaq advanced 2.4%. —Imbert

2:08 pm: Fed-fueled rally has gone too far, Marks says

Billionaire investor Howard Marks became the latest high profile investor to warn that the market rebound has gone too far given the uphill battle of developing a cure for Covid-19 and its economic impact in the meanwhile.

Marks told Bloomberg News that he believes markets will eventually face more turbulence once the Federal Reserve’s unprecedented, but nonetheless temporary support mechanisms fade.

“Those of us in the markets believe that stocks and bonds are selling at prices they wouldn’t sell at if the Fed were not the dominant force,” Marks said in a Bloomberg “Front Row” interview. “So if the Fed were to recede, we would all take over as buyers, but I don’t think at these levels.” —Franck

1:38 pm: Stocks hitting new all-time highs

The S&P 500 jumped more than 3% on Monday as broad market strength pushed the index higher. All 11 S&P sectors were in the green, with a number of stocks jumping to all-time highs. –Stevens, Hayes

  • Chipotle Mexican Grill trading at all-time high levels back to its IPO in Jan. 2006
  • Dollar General trading at all-time high levels back to its IPO in Nov. 2009
  • Home Depot trading at all-time high levels back to its IPO in Sept. 1981
  • Nvidia trading at all-time high levels back to its IPO in Jan. 1999
  • Paypal trading at all-time high levels after its spin-off from eBay in July 2015

11:55 am: Markets at midday: Stocks rally on coronavirus vaccine hopes

Around midday, the major averages were up sharply as investors cheered optimism about a potential coronavirus vaccine from Moderna. The Dow traded 800 points, or 3.4%. The S&P 500 gained 3% while the Nasdaq advanced 2.4%. If these gains hold, it would be the Dow’s best day since early April along with the S&P 500. —Imbert

11:25 am: Spirit Airlines stock soars 20% after Evercore ISI upgrade

The firm upgraded the low-cost carrier to outperform from in line as states re-open and consumers return to leisure destinations like Las Vegas and Orlando. “Demand is stabilizing, July a good test of new normal,” the analyst said. “Leisure, low-cost focus likely well-suited for the demand we are going to see in the early innings of this unique recovery.” The firm kept its price target at $12. —Bloom

11:10 am: Oil is ‘back,’ Trump says

President Donald Trump commented on Monday’s jump in oil prices, tweeting “oil (energy) is back!!!!” West Texas Intermediate, the U.S. oil benchmark, surged 12.57% to trade at $33.09 per barrel. However, it’s still down more than 45% this year amid the pandemic, which has sapped worldwide demand. – Stevens

10:42 am: High-beta stocks rally, volatile names like L Brands, Align Technology lead market higher

Some of the S&P 500’s most volatile stocks led the market’s rally on Monday as optimism about a potential Covid-19 vaccine carried equities up across the board. The Invesco S&P High Beta ETF (SPHB) rose 6.77%, on pace for its best day since April 6, as volatile stocks like L Brands, Apache Corp., Align Technology and Harley-Davidson all rose more than 10%. High-beta stocks are those that are correlated with the S&P 500 but at an amplified magnitude. —Franck, Francolla

10:35 am: Goldman Sachs raises price target on Moderna to a Street high as coronavirus ‘vaccine data hits the mark’

The firm raised its price target on Moderna to $105 from $63 after the biotech company’s coronavirus vaccine trial showed promising early results. “MRNA reported encouraging Ph1 mRNA-1273 (COVID-19 vaccine) interim safety and immunogenicity data. The vaccine was safe and well tolerated and all participants across the three dose levels (25ug,100ug,250ug) developed antibodies against SARS-CoV-2 by day 15 after a single dose,” the firm said. —Bloom

10:25 am: Reopening stocks lead the rally

Stocks poised to benefit from a reopening of economies led the way higher on Monday. Cruise lines, airlines and retailers were some of the industries jumping, as hopes of reopening fuels risk appetite around the beaten down stocks. Delta Air Lines rose 8.5% and United Airlines jumped 12%. Southwest Airlines gained 9%. American Airlines gained more than 5%. Cruise lines Carnival and Norwegian Cruise Line rose 10.6% and 12.7%, respectively. Retail also got a lift on Monday with Kohl’s jumping more than 7%. TJX Companies rose 5% and Ross Stores jumped 4.5%. — Fitzgerald 

10:15 am: Covid-19 index rallies

CNBC’s Covid-19 Testing & Treatment Index surged more than 4% on Monday as optimism around a potential coronavirus vaccine surged. The index was driven higher by a 4.6% jump in Novavax and a 20% rally in Moderna. Vir Biotechnology also traded more than 15% higher. —Imbert, Francolla

10:10 am: Lululemon a direct beneficiary of the work-from-home trend analyst says 

Piper Sandler raised its price target on Lululemon to $265 per share from $249 per share on Monday and said its bullish on the athletic apparel retailer as more consumers stay home. We see LULU as a direct beneficiary of this work-from-home trend as they appeal to comfort and functional apparel. Our observations suggest their online business has been accelerating rapidly despite stores being closed,” the firm said. Shares of the company are up 2.8% in early trading. —Bloom

10:07 am: Disney jumps more than 9% as some shopping areas prepare to reopen

Shares of Disney gained more than 9% on Monday after the company said that it will partially reopen its Disney Springs resort in Florida on Wednesday. All visitors will be required to wear a face mask, and other safety precautions include contactless pay options. Separately, the latest round of filings on Friday showed that David Einhorn’s Greenlight Capital bought shares of Disney in the first quarter amid the market rout. Shares of the media giant have slipped nearly 18% this year. – Stevens

10:00 am: NYSE advancers lead decliners 19-1 in early trading

Around 19 stocks traded higher at the New York Stock Exchange for every decliner amid rising hope for a potential coronavirus vaccine. Overall, 2,608 NYSE-listed stocks were up while 163 declined, according to FactSet data. —Imbert

9:55 am: Bank stocks rally

Bank stocks rallied across the board on Monday as hope around a potential coronavirus vaccine raised expectations of a faster economic reopening and capped loan default risk. Bank of America and Citigroup both rose more than 4% while JPMorgan Chase advanced 3.6% Wells Fargo advanced 5.5%. —Imbert

9:47 am: Stay-at-home stocks slump

Two of the most notable “stay-at-home” stocks — Netflix and Amazon –were in the red on Monday as investors rotated to stocks that benefit from the economy reopening. Streaming giant Netflix ticked 1.2% lower, after rallying nearly 40% in 2020. E-commerce juggernaut Amazon slipped 0.6% in early trading on Monday. Shares of Amazon have gained nearly 30% this year as millions of Americans stock up on food and household items, while avoiding physical stores. — Fitzgerald 

9:38 am: Here are Monday’s biggest analyst calls of the day: Best Buy, Nvidia, Dollar Tree & more

  • Goldman Sachs initiated Dollar General and Dollar Tree as buy.
  • BMO upgraded Nvidia to outperform from market perform.
  • Telsey upgraded Best Buy to outperform from market perform.
  • Wells Fargo upgraded SurveyMonkey to overweight from equal weight.
  • Bank of America upgraded Kraft Heinz to buy from neutral.
  • Bank of America downgraded Square to underperform from buy.
  • Wedbush upgraded Williams-Sonoma to outperform from neutral.
  • DA Davidson upgraded Palo Alto Networks to buy from neutral.

PRO Subscribers read more here. —Bloom

9:30 am: Stocks open sharply in the green, Dow up 600 points

U.S. equities started Monday with steep gains, as a possible Covid-19 vaccine and economy reopenings kindled risk appetite among investors. The Dow Jones Industrial Average soared 680 points after the opening bell. The S&P 500 and Nasdaq Composite rose 2.46% and 1.8%, respectively. Monday’s gains wiped out all of the Dow’s losses for the month of May. — Fitzgerald

9:20 am: Dollar Tree, Dollar General jump as Goldman initiates coverage at buy

Shares of Dollar Tree and Dollar General gained roughly 2% during Monday’s premarket trading after Goldman Sachs initiated coverage on the stocks with a buy rating. “We see the dollar stores as well positioned in this uncertain macro economic backdrop,” the firm’s analysts led by Kate McShane said. “The dollar stores bring a powerful combination of value and convenience to the cash-strapped consumer. Add elements of unit growth, counter-cyclicality and supportive demographics to this mix, and you get attractive business models slated to perform well in the face of a recession.” The firm has a 12-month price target of $202 on shares of Dollar General, which is 11% above where the stock currently trades. Shares have gained roughly 16% this year. When it comes to Dollar Tree, Goldman sees the stock hitting $89 in the next 12 months, which implies an 18% upside. Shares have shed 20% this year. – Stevens

8:40 am: Goldman adjusts second, third and fourth quarter EPS estimates

Goldman Sachs still sees 2020 S&P 500 earnings coming in at $110 and $170 in 2021, but following first quarter earnings results, the firm adjusted its breakdown for how it sees each quarter performing. “We now forecast S&P 500 year/year EPS growth of -70% in 2Q (from -123% previously), -30% in 3Q (from -21%), and -17% in 4Q (from +27%),” the Goldman strategists led by David Kostin said in a recent note to clients. The new forecast is based on four takeaways from Q1 results, including the index’s partial insulation relative to the economy due to its large-cap tilt, as well as companies shifting business models to capitalize on strength in digital. The upward revision for Q2 is based on the health of companies that account for 20% of the index, while the downward revision for the second half of the year reflects “a more gradual recovery.” Looking ahead, Goldman said the recovery will be uneven, with “EPS in cyclical sectors unlikely to recover to 2019 levels by 2021.” – Stevens

8:35 am: Banks bounce big in early trading

Bank stocks were up sharply ahead of the open, after Fed Chairman Jerome Powell assured the market the Fed is not out of bullets and that it can and will do more.  Citigroup, PNC, USB and Wells were all up more than 4%. JPMorgan was up 3.5%. Goldman  Sachs was also higher, gaining 2.5% even though Warren Buffett’s Berkshire Hathaway disclosed it sold of most of its long held stake. Banks rallied last week before losing steam with the broader market Friday. Buffett’s Berkshire did raise its stake in PNC, and trimmed JPMorgan.  “It’s the group that’s been the second or third worst performing throughout the cycle, and for obvious reasons, low interest rates, a flattish curve. They were due for an oversold bounce. It started last week,” said Art Hogan of National  Securities. —Domm

8:10 am: Oil prices jump nearly 10% as contract nears expiration

U.S. oil benchmark West Texas Intermediate jumped on Monday, one day ahead of the contract’s expiration date. The contract for June delivery gained $2.78, or 9.45%, to trade at $32.21 per barrel. International benchmark Brent crude jumped 6.4% to $34.58 per barrel. Each contract is coming off its third straight week of gains, as production cuts as well as an uptick in demand have supported prices. The longer-term and more actively traded WTI contracts also moved higher. Oil for July delivery jumped 8% to trade at $31.89, while the contract for August delivery traded 7.4% higher at $32.33. – Stevens

8:00 am: BMO goes all in on Nvidia

Wall Street firm BMO Capital Markets upgraded shares of Nvidia to outperform from market perform on Monday morning, sending shares of the chip stock up nearly 3% in premarket trading. BMO also hiked its price target to $425 per share from $285 per share, implying a 20% rally from Friday’s closing price of $339.63 per share. “We have stayed on the sidelines long enough on the NVDA shares,” BMO analyst Ambrish Srivastava said in a note to clients title “entering beat mode.” “While there is no one single event we can point to which has led us to change our thinking, the continued execution on the data center side, along with the latest product rollout, has helped. We believe NVIDIA is uniquely positioned to continue to benefit from a massive shift in the compute landscape,” added Srivastava. – Fitzgerald

7:56 am: Futures gain steam on Moderna vaccine optimism 

Futures accelerated gains, implying a steep rally at the open on Monday following positive news about a Moderna covid-19 vaccine. Dow futures popped 550 points. The S&P 500 futures pointed to gains of 65 points and the Nasdaq futures were up 166 points. —Fitzgerald 

7:45 am: Moderna pops on positive covid-19 vaccine trials

Shares of Moderna rose nearly 20% in premarket trading on Monday after the drug maker reported “positive data” for its coronavirus vaccine. The early-stage human trial showed the vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday. At day 43, about two weeks after the second dose was given to participants, levels of antibodies were at the levels generally seen in blood samples from people who recovered from the disease, the company said. “These interim Phase 1 data, while early, demonstrate that vaccination with mRNA-1273 elicits an immune response of the magnitude caused by natural infection starting with a dose as low as 25 µg,” Tal Zaks, the chief medical officer at Moderna, said in a statement. Shares of Moderna are up more than 240% this year.  –Fitzgerald

7:36 am: Reopening stocks rise 

Stocks poised to benefit from a reopening of the economies stifled by the coronavirus pandemic rose in premarket trading on Monday. Cruise lines, airlines and retailers are some of the industries jumping, as hopes of reopening kindles cautious risk appetite about the beaten down stocks. Delta Air Lines rose 4.3% in extended trading before the bell on Monday. United Airlines and Southwest Airlines both rose more than 5%. American Airlines gained 3.5%. Cruise lines Carnival and Norwegian Cruise Line rose 5.3% and 4.3%, respectively. Retails also got a lift on Monday with Kohl’s and Nordstrom jumping more than 3%. TJX Companies rose 2.5%. —Fitzgerald

7:27 am: Powell says ‘there’s a lot more’ the Fed can do to help

Even after the Federal Reserve has unloaded an unprecedented level of help for markets and the economy, Chairman Jerome Powell said there are still more weapons available. “Well, there’s a lot more we can do,” Powell said during a “60 Minutes” interview aired Sunday evening on CBS. “But I will say that we’re not out of ammunition by a long shot. No, there’s really no limit to what we can do with these lending programs that we have. So there’s a lot more we can do to support the economy, and we’re committed to doing everything we can as long as we need to.” Powell also said he sees GDP potentially falling by more than 30% but he does not foresee another Depression. – Cox 

7:17 am: Dow futures surge as Wall Street tries to recover from last week’s decline

U.S. stock futures traded sharply higher on Monday morning as investors aimed to claw back some of last week’s losses amid optimism around the economy reopening. Dow futures traded 400 points higher, or 1.7%. S&P 500 and Nasdaq 100 futures gained 1.6% and 1.4%, respectively. The S&P 500 fell  2.2% last week, notching its worst week since March. The Dow industrials finished the week down 2.65%, its worst week since April 3. —Imbert

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

—with reporting from CNBC’s Jeff Cox, Michael Bloom, Thomas Franck and Patti Domm. 

Read More